Table 5. Signaling pathways enriched in the MAN2A1 high-expression group.
Signaling pathway | NES | NOM p-value | FDR q-value |
---|---|---|---|
KEGG_wnt signaling pathway | 2.361 | ≤0.001 | 0.003 |
KEGG_long term potentiation | 2.328 | ≤0.001 | 0.001 |
KEGG_oocyte meiosis | 2.296 | ≤0.001 | 9.30E-04 |
KEGG_ubiquitin mediated proteolysis | 2.281 | ≤0.001 | 6.98E-04 |
KEGG_neurotrophin signaling pathway | 2.259 | ≤0.001 | 0.001 |
KEGG_GNRH signaling pathway | 2.228 | ≤0.001 | 0.001 |
KEGG_progesterone mediated oocyte maturation | 2.223 | ≤0.001 | 9.62E-04 |
KEGG_colorectal cancer | 2.223 | ≤0.001 | 8.42E-04 |
KEGG_pathways in cancer | 2.211 | ≤0.001 | 7.48E-04 |
KEGG_prostate cancer | 2.201 | ≤0.001 | 6.73E-04 |
KEGG_TGF beta signaling pathway | 2.195 | ≤0.001 | 6.12E-04 |
KEGG_lysine degradation | 2.193 | ≤0.001 | 5.61E-04 |
KEGG_MAPK signaling pathway | 2.184 | ≤0.001 | 5.18E-04 |
KEGG_ERBB signaling pathway | 2.176 | ≤0.001 | 7.73E-04 |
KEGG_apoptosis | 2.176 | ≤0.001 | 7.22E-04 |
KEGG_melanogenesis | 2.174 | ≤0.001 | 7.41E-04 |
KEGG_butanoate metabolism | 2.171 | ≤0.001 | 6.97E-04 |
KEGG_phosphatidylinositol signaling system | 2.171 | ≤0.001 | 6.58E-04 |
KEGG_P53 signaling pathway | 2.169 | ≤0.001 | 6.24E-04 |
KEGG_beta alanine metabolism | 2.161 | ≤0.001 | 7.03E-04 |
NES, normalized enrichment score; NOM, nominal; FDR, false discovery rate.